Tone mix
Week by week 52 weeks
Share of Nuvation Bio Inc.'s 143 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Aug 11, 2025 · tone -100Nuvation Bio (NYSE:NUVB) Lowered to "Sell" Rating by Wall Street Zen-133
- Week of Jan 19, 2026 · tone -50Nuvation Bio Inc. (NUVB) Price Target Lowered as IBTROZI Sales Meet Expectations-86
- Week of Oct 27, 2025 · tone 0Nuvation Bio to Participate in Upcoming Investor Conferences-74
- Week of Aug 25, 2025 · tone +100H.C. Wainwright Reiterates a Buy Rating on Nuvation Bio (NUVB)+70
- Week of Aug 31, 2026 · tone +99Cramer's lightning round: Nuvation Bio 'is a pure spec'+68
- Week of Sep 15, 2025 · tone +100Nuvation Bio Says Japan Approves IBTROZI For ROS1+ Advanced Non-small Cell Lung Cancer Treatment+64
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Nuvation Bio Inc. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 2 | 0 |
| Last 30 sessions | 10 | +20 |
| Last 90 sessions | 34 | +28 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Wednesday, October 28, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletHead to Head Analysis: Immunocore (NASDAQ:IMCR) & Nuvation Bio (NYSE:NUVB)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head to Head Analysis: Immunocore (NASDAQ:IMCR) & Nuvation Bio (NYSE:NUVB) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 22, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.prnewswire.com · 1 outletNuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Nuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026 | www.prnewswire.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 19, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletCritical Review: Nuvation Bio (NYSE:NUVB) vs. OSR (NASDAQ:OSRH)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Critical Review: Nuvation Bio (NYSE:NUVB) vs. OSR (NASDAQ:OSRH) | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 7, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletNuvation Bio Inc. (NYSE:NUVB) Receives Consensus Recommendation of "Moderate Buy" from AnalystsPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Nuvation Bio Inc. (NYSE:NUVB) Receives Consensus Recommendation of "Moderate Buy" from Analysts | www.dailypolitical.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 5, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.tickerreport.com · 1 outletNuvation Bio (NYSE:NUVB) Research Coverage Started at CitigroupNeutral
- www.tickerreport.com · 1 outletNuvation Bio Inc. (NYSE:NUVB) Stock Has Average Price Target of $13.38Neutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Nuvation Bio (NYSE:NUVB) Research Coverage Started at Citigroup | www.tickerreport.com | 1 | Neutral |
| Nuvation Bio Inc. (NYSE:NUVB) Stock Has Average Price Target of $13.38 | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Nuvation Bio Inc., not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.